These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 10704616)
1. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients. Jain SK; McVie R; Meachum ZD; Smith T Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616 [TBL] [Abstract][Full Text] [Related]
2. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients. Jain SK; McVie R; Jaramillo JJ; Chen Y Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification. Julier K; Mackness MI; Dean JD; Durrington PN Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein abnormalities in well-treated type II diabetic patients. Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219 [TBL] [Abstract][Full Text] [Related]
5. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196 [TBL] [Abstract][Full Text] [Related]
6. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028 [TBL] [Abstract][Full Text] [Related]
7. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women. al-Muhtaseb N; al-Yuosuf AR; Bajaj JS Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693 [TBL] [Abstract][Full Text] [Related]
8. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL; Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042 [TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Kesavulu MM; Giri R; Kameswara Rao B; Apparao C Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018 [TBL] [Abstract][Full Text] [Related]
10. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151 [TBL] [Abstract][Full Text] [Related]
11. Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus. Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Arrol S; Mackness M Arterioscler Thromb; 1992 Aug; 12(8):920-8. PubMed ID: 1637789 [TBL] [Abstract][Full Text] [Related]
12. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262 [TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH; Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968 [TBL] [Abstract][Full Text] [Related]
16. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650 [TBL] [Abstract][Full Text] [Related]
17. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Sørensen LP; Andersen IR; Søndergaard E; Gormsen LC; Schmitz O; Christiansen JS; Nielsen S Diabetes; 2011 Jan; 60(1):88-96. PubMed ID: 20858686 [TBL] [Abstract][Full Text] [Related]
18. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey. Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control. Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192 [TBL] [Abstract][Full Text] [Related]
20. Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1. Strobl W; Widhalm K; Schober E; Frisch H; Pollak A; Westphal G Acta Paediatr Scand; 1985 Nov; 74(6):966-71. PubMed ID: 4090971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]